CU24322B1 - QUINOLIN-2-AMINA DERIVATIVES OF THE FORMULA (Ig) AND SALES DERIVED - Google Patents

QUINOLIN-2-AMINA DERIVATIVES OF THE FORMULA (Ig) AND SALES DERIVED

Info

Publication number
CU24322B1
CU24322B1 CUP2015000025A CU20150025A CU24322B1 CU 24322 B1 CU24322 B1 CU 24322B1 CU P2015000025 A CUP2015000025 A CU P2015000025A CU 20150025 A CU20150025 A CU 20150025A CU 24322 B1 CU24322 B1 CU 24322B1
Authority
CU
Cuba
Prior art keywords
group
hydrogen atom
formula
alkyl
atom
Prior art date
Application number
CUP2015000025A
Other languages
Spanish (es)
Other versions
CU20150025A7 (en
Inventor
Florence Mahuteau
Romain Najman
Jamal Tazi
Original Assignee
Abivax
Centre Nat Rech Scient
Inst Curie
Univ Montpellier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP20090305540 external-priority patent/EP2266972A1/en
Application filed by Abivax, Centre Nat Rech Scient, Inst Curie, Univ Montpellier filed Critical Abivax
Priority claimed from PCT/IB2010/052652 external-priority patent/WO2010143170A2/en
Publication of CU20150025A7 publication Critical patent/CU20150025A7/en
Publication of CU24322B1 publication Critical patent/CU24322B1/en

Links

Abstract

<p>Un compuesto de fórmula (Ig) o sales farmacéuticamente aceptables de los mismos, donde las sales farmacéuticamente aceptables son seleccionadas de hidrobromada, tartrato, citrato, trifluoroacetato, ascorbato, hidroclorido, tartrato, triflato, maleato, mesilato, formato, acetato y fumarato.</p> <p>ESPACIO PARA FORMULA </p> <p>Donde R independientemente representa un átomo de hidrogeno, un átomo de halógeno o un grupo seleccionado entre un grupo (C1-C3) alquilo, un grupo –CN, un grupo hidroxilo, un grupo –COOR1, un grupo fluoroalquilo de C1-C3, un grupo fluoroalcoxi de C1-C3, un grupo –NO2, un grupo –NR1R2 y un grupo alcoxi de C1-C4, n es 1 o 2, n' es 1 o 2, R' es un átomo de hidrógeno o un grupo seleccionado entre un grupo (C1-C3) alquilo, un átomo de halógeno, un grupo hidroxilo, un grupo –COOR1, un grupo –NO2, un grupo –NR1R2, un grupo alcoxi de C1-C4, y un grupo –CN, R” es un átomo de hidrógeno o (C1-C4) alquilo, R1 y R2 son independientemente un átomo de hidrógeno o un grupo alquilo C1-C3 con la condición de que R y R' no son simultáneamente un átomo de hidrógeno y cuando n y n' son 1 y R es un átomo de hidrógeno entonces R' no es un grupo –COOH.</p><p> A compound of formula (Ig) or pharmaceutically acceptable salts thereof, where the pharmaceutically acceptable salts are selected from hydrobromide, tartrate, citrate, trifluoroacetate, ascorbate, hydrochloride, tartrate, triflate, maleate, mesylate, format, acetate and fumarate. </p> <p> FORMULA SPACE </p> <p> Where R independently represents a hydrogen atom, a halogen atom or a group selected from a (C1-C3) alkyl group, a –CN group , a hydroxyl group, a -COOR1 group, a C1-C3 fluoroalkyl group, a C1-C3 fluoroalkoxy group, a -NO2 group, a -NR1R2 group and a C1-C4 alkoxy group, n is 1 or 2, n 'is 1 or 2, R' is a hydrogen atom or a group selected from a (C1-C3) alkyl group, a halogen atom, a hydroxyl group, a -COOR1 group, a -NO2 group, a group - NR1R2, a C1-C4 alkoxy group, and a -CN, R "group is a hydrogen atom or (C1-C4) alkyl, R1 and R2 are independently an atom. omo of hydrogen or a C1-C3 alkyl group with the proviso that R and R 'are not simultaneously a hydrogen atom and when nyn' are 1 and R is a hydrogen atom then R 'is not a –COOH group. < / p>

CUP2015000025A 2009-06-12 2010-06-14 QUINOLIN-2-AMINA DERIVATIVES OF THE FORMULA (Ig) AND SALES DERIVED CU24322B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18654409P 2009-06-12 2009-06-12
EP20090305540 EP2266972A1 (en) 2009-06-12 2009-06-12 New chemical molecules that inhibit the splicing mechanism for treating diseases resulting from splicing anomalies
PCT/IB2010/052652 WO2010143170A2 (en) 2009-06-12 2010-06-14 Compounds useful for treating premature aging and in particular progeria

Publications (2)

Publication Number Publication Date
CU20150025A7 CU20150025A7 (en) 2015-11-27
CU24322B1 true CU24322B1 (en) 2018-02-08

Family

ID=55659614

Family Applications (3)

Application Number Title Priority Date Filing Date
CUP2015000027A CU24323B1 (en) 2009-06-12 2010-06-14 QUINOLIN AND QUINOXALINA DERIVED FROM THE FORMULA (Ii), (Ij), (Ij '), (Ij' ') and (Ij' '') AND SALES DERIVED
CUP2015000025A CU24322B1 (en) 2009-06-12 2010-06-14 QUINOLIN-2-AMINA DERIVATIVES OF THE FORMULA (Ig) AND SALES DERIVED
CUP2015000028A CU24319B1 (en) 2009-06-12 2010-06-14 QUINOLIN-2-AMINA AND QUINOXALINE DERIVED FROM THE FORMULA (Ik) and (Ip) AND DERIVED SALTS

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CUP2015000027A CU24323B1 (en) 2009-06-12 2010-06-14 QUINOLIN AND QUINOXALINA DERIVED FROM THE FORMULA (Ii), (Ij), (Ij '), (Ij' ') and (Ij' '') AND SALES DERIVED

Family Applications After (1)

Application Number Title Priority Date Filing Date
CUP2015000028A CU24319B1 (en) 2009-06-12 2010-06-14 QUINOLIN-2-AMINA AND QUINOXALINE DERIVED FROM THE FORMULA (Ik) and (Ip) AND DERIVED SALTS

Country Status (1)

Country Link
CU (3) CU24323B1 (en)

Also Published As

Publication number Publication date
CU24323B1 (en) 2018-02-08
CU20150025A7 (en) 2015-11-27
CU24319B1 (en) 2018-02-08
CU20150027A7 (en) 2015-11-27
CU20150028A7 (en) 2015-11-27

Similar Documents

Publication Publication Date Title
ES2509820T3 (en) Indazole derivatives as kinase inhibitors for cancer treatment
CU24461B1 (en) USEFUL COMPOUNDS TO TREAT PREMATURE AGING AND IN PARTICULAR PROGERIA
AR049739A1 (en) ARIL-PYRIDINE DERIVATIVES
PE20080559A1 (en) SUBSTITUTED HETEROARIL DERIVATIVES
AR058287A1 (en) ISOQUINOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION
AR068413A2 (en) 8-AMINO DERIVATIVES, PREPARATION METHODS, PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THERAPY
ME01421B (en) 5-substituted quinazolinone derivatives as antitumor agents
EA200602060A1 (en) DERIVATIVES PYRROLIDIN-2-SHE AND PIPERIDIN-2-SHE USED AS INHIBITORS 11-BETA-HYDROXYSTEROID-DEGYDROGENASE
AR078045A1 (en) PIRIMIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM AND THEIR USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF CANCER
AR041260A1 (en) PIPERAZINAS REPLACED BY HETEROCICLES FOR THE TREATMENT OF CHICHOPHRENIA
AR058077A1 (en) DERIVATIVES OF PHENOXYACETIC ACIDS
AR061371A1 (en) AMINO - IMIDAZOLONAS AND ITS USE AS A MEDICINAL PRODUCT FOR ALZHEIMER&#39;S DISEASE AND OTHER NEURODEGENERATIVE DISEASES.
AR047817A1 (en) DERIVATIVES OF ARIL- AND HETEROARILPIPERIDINCARBOXILATOS, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
CY1112283T1 (en) METHOD FOR PREPARING 17-Vinyl-triflates as intermediates
AR072227A1 (en) SUBSTITUTED TRIAZINONA DERIVATIVES
AR033046A1 (en) DERIVATIVES OF 4,5-DIHIDRO-1H-PIRAZOL HAVING CB1 ANTAGONIST ACTIVITY, PHARMACEUTICAL COMPOSITION AND PREPARATION METHODS
AR025975A1 (en) CHEMICAL COMPOUNDS.
RS51674B (en) Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists
AR081426A1 (en) PIRAZOL DERIVATIVES INHIBITORS OF THE SIGMA RECEIVER
AR049699A1 (en) PIRIMIDINE DERIVATIVES
AR062209A1 (en) MGLUR5 METABOTROPIC GLUTAMATE RECEPTORS MODULATING PIRAZOLOPIRIMIDINES, PROCESS FOR PREPARATION, MEDICATIONS CONTAINING THEM AND USES IN THE PREVENTION AND / OR TREATMENT OF ACUTE AND CHRONIC NEUROLOGICAL DISORDERS.
EA201170096A1 (en) SUBSTITUTED PYRIMIDON DERIVATIVES
PE20061156A1 (en) BENZAMIDE DERIVATIVES AS INHIBITING AGENTS OF THE GLYCINE TRANSPORTER
AR054102A1 (en) DERIVATIVES OF FENIL-PIPERAZINA-METANONA. PROCESSES OF OBTAINING AND PHARMACEUTICAL COMPOSITIONS
AR049995A1 (en) A PROCEDURE FOR THE PREPARATION OF DERIVATIVES N-PIPERIDINO-1,5-DIFENILPIRAZOL-3-CARBOXAMIDA